Released Sep 14, 2012, after the close
10-Q filed Sep 14, 2012, 45 days after period end · 0001354488-12-004893
Q3 2012 · 10-Q
Revenue—
Net Income$1.28M$1.28M −14.9% vs Q3 2011+7.4% vs Q2 2012
EPS Diluted$0.06$0.06 −16.4% vs Q3 2011+7.7% vs Q2 2012
Gross Profit$2,598,826+30.0%
Operating Income$1,572,666+34.7%
Operating Cash Flow$1,143,060+8.4%
Free Cash Flowderived$1,083,077+3.0%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Net Income | $1.28M | $1.50M | $121.41K |
| EPS Diluted | $0.06 | $0.07 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR